Tracon Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tracon Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Tracon Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.91M, a 274% decline year-over-year.
  • Tracon Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$7.31M, a 64% increase year-over-year.
  • Tracon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$9.27M, a 66.8% increase from 2022.
  • Tracon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$27.9M, a 1.6% increase from 2021.
  • Tracon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$28.3M, a 74.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$9.27M +$18.6M +66.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$27.9M +$453K +1.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$28.3M -$12.1M -74.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 -$16.2M +$6.07M +27.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-08
2019 -$22.3M +$12.4M +35.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 -$34.7M -$16.5M -90.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$18.2M +$7.77M +29.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 -$26M -$2.51M -10.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$23.5M -$17.3M -280% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$6.18M +$1.38M +18.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$7.56M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.